Your browser doesn't support javascript.
loading
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials.
Flaherty, Keith T; Hennig, Michael; Lee, Sandra J; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M M; Hauschild, Axel; Kefford, Richard; Kirkwood, John M; Long, Georgina V; Lorigan, Paul; Mackensen, Andreas; McArthur, Grant; O'Day, Steven; Patel, Poulam M; Robert, Caroline; Schadendorf, Dirk.
  • Flaherty KT; Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Hennig M; Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany.
  • Lee SJ; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy.
  • Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Eggermont AM; Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France.
  • Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany.
  • Kefford R; Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia.
  • Kirkwood JM; Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Long GV; Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia.
  • Lorigan P; Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK.
  • Mackensen A; Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany.
  • McArthur G; Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia.
  • O'Day S; Beverly Hills Cancer Center, Beverly Hills, CA, USA.
  • Patel PM; Academic Unit of Oncology, University of Nottingham, Nottingham, UK.
  • Robert C; Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: dirk.schadendorf@uk-essen.de.
Lancet Oncol ; 15(3): 297-304, 2014 Mar.
Article en En | MEDLINE | ID: mdl-24485879
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Melanoma Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Melanoma Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2014 Tipo del documento: Article